Albert Sabin

Seven years later, Langmuir faced a similar decision after EIS investigators found that in very rare cases—less than one person out of every million vaccinated—the oral polio vaccine developed by Albert Sabin caused paralysis.

The Panic Virus Seth Mnookin 2011

Two weeks later, Sencer took Jonas Salk, Albert Sabin, and a coterie of other leading virologists to meet with Ford in the White House.

The Panic Virus Seth Mnookin 2011

Two weeks later, Sencer took Jonas Salk, Albert Sabin, and a coterie of other leading virologists to meet with Ford in the White House.

The Panic Virus Seth Mnookin 2011

Seven years later, Langmuir faced a similar decision after EIS investigators found that in very rare cases—less than one person out of every million vaccinated—the oral polio vaccine developed by Albert Sabin caused paralysis.

The Panic Virus Seth Mnookin 2011

Seven years later, Langmuir faced a similar decision after EIS investigators found that in very rare cases—less than one person out of every million vaccinated—the oral polio vaccine developed by Albert Sabin caused paralysis.

The Panic Virus Seth Mnookin 2011

Two weeks later, Sencer took Jonas Salk, Albert Sabin, and a coterie of other leading virologists to meet with Ford in the White House.

The Panic Virus Seth Mnookin 2011

FDR AND THE POLIO CRISIS, a National Park Service ranger discusses the president's struggles with the disease, the founding of the March of Dimes and the research of Jonas Salk and Albert Sabin. 6: 30 p.m.,

D.C. community calendar, Sept. 23 to 30, 2010 2010

Dr. Chanock apprenticed with Albert Sabin, who developed the oral polio vaccine, and decided early on to focus his career on tracking down and warding off the unknown viruses that caused disease epidemics among babies.

Robert M. Chanock, virologist who studied children's diseases, dies at 86 2010

Overcoming Salk's contamination problems, Albert Sabin developed an oral vaccine in 1960.

Landmarks 2008

Jonas Salk and Albert Sabin invented two different and enormously successful polio vaccines, but neither received the large financial multipliers inherent in their blockbuster innovations.

Innovation, Money 2008